4H02 image
Deposition Date 2012-09-07
Release Date 2013-05-01
Last Version Date 2024-02-28
Entry Detail
PDB ID:
4H02
Keywords:
Title:
Crystal structure of P. falciparum Lysyl-tRNA synthetase
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.91 Å
R-Value Free:
0.29
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Lysyl-tRNA synthetase
Gene (Uniprot):PF3D7_1350100
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:507
Number of Molecules:8
Biological Source:Plasmodium falciparum
Primary Citation
Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development.
Acta Crystallogr.,Sect.D 69 785 795 (2013)
PMID: 23633587 DOI: 10.1107/S0907444913001923

Abstact

Aminoacyl-tRNA synthetases are essential enzymes that transmit information from the genetic code to proteins in cells and are targets for antipathogen drug development. Elucidation of the crystal structure of cytoplasmic lysyl-tRNA synthetase from the malaria parasite Plasmodium falciparum (PfLysRS) has allowed direct comparison with human LysRS. The authors' data suggest that PfLysRS is dimeric in solution, whereas the human counterpart can also adopt tetrameric forms. It is shown for the first time that PfLysRS is capable of synthesizing the signalling molecule Ap4a (diadenosine tetraphosphate) using ATP as a substrate. The PfLysRS crystal structure is in the apo form, such that binding to ATP will require rotameric changes in four conserved residues. Differences in the active-site regions of parasite and human LysRSs suggest the possibility of exploiting PfLysRS for selective inhibition. These investigations on PfLysRS further validate malarial LysRSs as attractive antimalarial targets and provide new structural space for the development of inhibitors that target pathogen LysRSs selectively.

Legend

Protein

Chemical

Disease

Primary Citation of related structures